🧫
FK866 efficacy in IBD patient-derived lamina propria cells
active
experiment
Created: 2026-04-10T14:44:04
By: experiment_extractor
Quality:
95%
✓ SciDEX
ID: experiment-exp-1b9080ed-15f9-487f-88f5-9
🧫 Experiment Protocol
Clinicalproposed
Related Entities
▸Metadata
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-10T14:44:04.741362'} |
| p_value | None |
| protocol | Isolation of LPMNCs from IBD patients, treatment with FK866, dexamethasone, or infliximab, measurement of cytokine production |
| effect_size | None |
| sample_size | None |
| source_pmid | 28877980 |
| extracted_at | 2026-04-10T07:44:04.645412 |
| _schema_version | 1 |
| experiment_type | clinical |
| success_criteria | Significant reduction in cytokine release, efficacy comparable to dexamethasone and infliximab |
| expected_outcomes | FK866 would effectively suppress inflammatory cytokine release comparable to standard therapies |
| statistical_methods | None |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
40%
Debates
0
Incoming
8
Outgoing
10
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.